BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 31278254)

  • 1. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.
    Czystowska-Kuzmicz M; Sosnowska A; Nowis D; Ramji K; Szajnik M; Chlebowska-Tuz J; Wolinska E; Gaj P; Grazul M; Pilch Z; Zerrouqi A; Graczyk-Jarzynka A; Soroczynska K; Cierniak S; Koktysz R; Elishaev E; Gruca S; Stefanowicz A; Blaszczyk R; Borek B; Gzik A; Whiteside T; Golab J
    Nat Commun; 2019 Jul; 10(1):3000. PubMed ID: 31278254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression.
    Bak SP; Alonso A; Turk MJ; Berwin B
    Mol Immunol; 2008 Dec; 46(2):258-68. PubMed ID: 18824264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
    Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
    J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
    Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
    J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. uPAR
    Porcelli L; Guida M; De Summa S; Di Fonte R; De Risi I; Garofoli M; Caputo M; Negri A; Strippoli S; Serratì S; Azzariti A
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33972390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The key role of IL-6-arginase cascade for inducing dendritic cell-dependent CD4(+) T cell dysfunction in tumor-bearing mice.
    Narita Y; Kitamura H; Wakita D; Sumida K; Masuko K; Terada S; Nakano K; Nishimura T
    J Immunol; 2013 Jan; 190(2):812-20. PubMed ID: 23248265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade.
    Kelleher RJ; Balu-Iyer S; Loyall J; Sacca AJ; Shenoy GN; Peng P; Iyer V; Fathallah AM; Berenson CS; Wallace PK; Tario J; Odunsi K; Bankert RB
    Cancer Immunol Res; 2015 Nov; 3(11):1269-78. PubMed ID: 26112921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients.
    Landskron J; Helland Ø; Torgersen KM; Aandahl EM; Gjertsen BT; Bjørge L; Taskén K
    Cancer Immunol Immunother; 2015 Mar; 64(3):337-47. PubMed ID: 25416072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
    Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
    J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
    Wei S; Kryczek I; Zou L; Daniel B; Cheng P; Mottram P; Curiel T; Lange A; Zou W
    Cancer Res; 2005 Jun; 65(12):5020-6. PubMed ID: 15958543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites.
    Wefers C; Duiveman-de Boer T; Yigit R; Zusterzeel PLM; van Altena AM; Massuger LFAG; De Vries IJM
    Front Immunol; 2018; 9():3156. PubMed ID: 30687337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase 1 is a key driver of immune suppression in pancreatic cancer.
    Menjivar RE; Nwosu ZC; Du W; Donahue KL; Hong HS; Espinoza C; Brown K; Velez-Delgado A; Yan W; Lima F; Bischoff A; Kadiyala P; Salas-Escabillas D; Crawford HC; Bednar F; Carpenter E; Zhang Y; Halbrook CJ; Lyssiotis CA; Pasca di Magliano M
    Elife; 2023 Feb; 12():. PubMed ID: 36727849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
    Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
    Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
    Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
    Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
    Liu J; Tan Z; He J; Jin T; Han Y; Hu L; Song J; Huang S
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33043974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use.
    Koido S; Nikrui N; Ohana M; Xia J; Tanaka Y; Liu C; Durfee JK; Lerner A; Gong J
    Gynecol Oncol; 2005 Nov; 99(2):462-71. PubMed ID: 16137749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
    Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
    JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8α
    Wan S; Wang S; Weng L; Zhang G; Lin Z; Fei X; Zhang F; Yang F; Wang J; Cai Z
    J Immunol; 2018 Mar; 200(5):1651-1660. PubMed ID: 29358274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity.
    Peng P; Yan Y; Keng S
    Oncol Rep; 2011 Mar; 25(3):749-62. PubMed ID: 21181093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8(+) T activation attenuates CD4(+) T proliferation through dendritic cells modification.
    Chen D; Wang Y; Wang H; Wu Y; Xia S; Zhang M
    Cell Immunol; 2015 Aug; 296(2):138-48. PubMed ID: 26022412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.